23andMe | 8-K: 23andme Announces Fda Clearance of Ind Application for Its Dual Mechanism Antibody, 23me-01473, Targeting Ulbp6
23andMe | 8-K: 23andme Announces Fda Clearance of Ind Application for Its Dual Mechanism Antibody, 23me-01473, Targeting Ulbp6
23andMe | 8-K：23andMe宣佈FDA批准其針對ULBP6的雙機制抗體23ME-01473的臨床申請
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。